↓ Skip to main content

Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers

Overview of attention for article published in BMC Cancer, July 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
4 tweeters

Citations

dimensions_citation
43 Dimensions

Readers on

mendeley
112 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers
Published in
BMC Cancer, July 2013
DOI 10.1186/1471-2407-13-339
Pubmed ID
Authors

Reka Pataky, Linlea Armstrong, Stephen Chia, Andrew J Coldman, Charmaine Kim-Sing, Barbara McGillivray, Jenna Scott, Christine M Wilson, Stuart Peacock

Abstract

Women with mutations in BRCA1 or BRCA2 are at high risk of developing breast cancer and, in British Columbia, Canada, are offered screening with both magnetic resonance imaging (MRI) and mammography to facilitate early detection. MRI is more sensitive than mammography but is more costly and produces more false positive results. The purpose of this study was to calculate the cost-effectiveness of MRI screening for breast cancer in BRCA1/2 mutation carriers in a Canadian setting.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 112 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Malaysia 1 <1%
Unknown 110 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 21 19%
Student > Bachelor 15 13%
Student > Master 11 10%
Researcher 9 8%
Student > Postgraduate 9 8%
Other 26 23%
Unknown 21 19%
Readers by discipline Count As %
Medicine and Dentistry 43 38%
Economics, Econometrics and Finance 11 10%
Nursing and Health Professions 9 8%
Business, Management and Accounting 4 4%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 19 17%
Unknown 22 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 July 2013.
All research outputs
#12,535,243
of 21,347,367 outputs
Outputs from BMC Cancer
#2,727
of 7,669 outputs
Outputs of similar age
#88,443
of 174,256 outputs
Outputs of similar age from BMC Cancer
#1
of 1 outputs
Altmetric has tracked 21,347,367 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,669 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 174,256 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them